Multivariate Analysis of Structural and Functional Neuroimaging Can Inform Psychiatric Differential Diagnosis.
depression
diagnosis
discriminative
multivariate linear method
schizophrenia
signatures of disease
validation
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
24 Dec 2020
24 Dec 2020
Historique:
received:
03
12
2020
revised:
16
12
2020
accepted:
18
12
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
31
12
2020
Statut:
epublish
Résumé
Traditional psychiatric diagnosis has been overly reliant on either self-reported measures (introspection) or clinical rating scales (interviews). This produced the so-called explanatory gap with the bio-medical disciplines, such as neuroscience, which are supposed to deliver biological explanations of disease. In that context the neuro-biological and clinical assessment in psychiatry remained discrepant and incommensurable under conventional statistical frameworks. The emerging field of translational neuroimaging attempted to bridge the explanatory gap by means of simultaneous application of clinical assessment tools and functional magnetic resonance imaging, which also turned out to be problematic when analyzed with standard statistical methods. In order to overcome this problem our group designed a novel machine learning technique, multivariate linear method (MLM) which can capture convergent data from voxel-based morphometry, functional resting state and task-related neuroimaging and the relevant clinical measures. In this paper we report results from convergent cross-validation of biological signatures of disease in a sample of patients with schizophrenia as compared to depression. Our model provides evidence that the combination of the neuroimaging and clinical data in MLM analysis can inform the differential diagnosis in terms of incremental validity.
Identifiants
pubmed: 33374207
pii: diagnostics11010019
doi: 10.3390/diagnostics11010019
pmc: PMC7823426
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Neurosci Biobehav Rev. 2008;32(1):175-91
pubmed: 17884165
Biol Psychiatry. 2018 Oct 15;84(8):582-590
pubmed: 29580569
Biol Psychiatry. 2017 May 15;81(10):886-897
pubmed: 27449797
Am J Psychiatry. 2003 Jan;160(1):156-64
pubmed: 12505815
Arch Gen Psychiatry. 2011 Apr;68(4):361-8
pubmed: 21135315
PLoS One. 2012;7(4):e35589
pubmed: 22536413
Brain Lang. 2018 Jan;176:42-47
pubmed: 29223785
Trends Pharmacol Sci. 2011 Sep;32(9):507-13
pubmed: 21700346
Neurosci Conscious. 2018 Mar 27;2018(1):niy005
pubmed: 30042858
Neuroimage. 2011 Sep 15;58(2):526-36
pubmed: 21723948
Brain Imaging Behav. 2016 Jun;10(2):548-58
pubmed: 26149196
Front Psychiatry. 2018 Feb 08;9:21
pubmed: 29472876
Front Hum Neurosci. 2013 May 29;7:235
pubmed: 23755002
J Neurosci. 2012 Jul 11;32(28):9582-7
pubmed: 22787044
CNS Neurosci Ther. 2018 Nov;24(11):1037-1052
pubmed: 30136381
Philos Trans R Soc Lond B Biol Sci. 2015 May 19;370(1668):
pubmed: 25823869
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Dialogues Clin Neurosci. 2015 Mar;17(1):89-97
pubmed: 25987867
Schizophr Bull. 2020 Apr 10;46(3):592-602
pubmed: 31586408
Neuroimage. 2002 Aug;16(4):1068-83
pubmed: 12202094
Front Hum Neurosci. 2015 Aug 06;9:430
pubmed: 26300757
Cortex. 2013 Apr;49(4):1046-55
pubmed: 22370252
Ann N Y Acad Sci. 2003 Apr;985:326-40
pubmed: 12724168
Schizophr Bull. 2008 Sep;34(5):888-903
pubmed: 18644853
Front Psychiatry. 2019 Sep 27;10:711
pubmed: 31611826
Schizophr Bull. 2013 Jan;39(1):120-9
pubmed: 21746807
Front Neurosci. 2009 May 01;3(1):34-45
pubmed: 19753095
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Front Psychiatry. 2020 Jan 08;10:924
pubmed: 31969840
J Psychopharmacol. 2014 Mar;28(3):254-69
pubmed: 24327450
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6173-8
pubmed: 18427123
Schizophr Bull. 2012 Jun;38(4):779-86
pubmed: 21177743
Neuropsychopharmacology. 2013 Oct;38(11):2131-9
pubmed: 23652286
Front Psychol. 2011 Nov 10;2:330
pubmed: 22084637
Neuroimage. 2010 Jan 1;49(1):939-46
pubmed: 19699306
Soc Cogn Affect Neurosci. 2015 Oct;10(10):1429-36
pubmed: 25809400
Front Psychiatry. 2019 Nov 25;10:869
pubmed: 31824359
Neuroimage. 1997 Nov;6(4):305-19
pubmed: 9417973
Front Hum Neurosci. 2010 Oct 25;4:192
pubmed: 21119772
Nat Neurosci. 2011 Sep 18;14(10):1245-6
pubmed: 21926985
J Affect Disord. 2008 Apr;107(1-3):181-6
pubmed: 18031825
Neurosci Biobehav Rev. 2014 Nov;47:36-52
pubmed: 25066091
Neuroimage. 2013 Apr 15;70:80-8
pubmed: 23266702
Neuron. 2012 Nov 21;76(4):790-803
pubmed: 23177963
Can J Psychiatry. 2004 Mar;49(3 Suppl 1):10S-16S
pubmed: 15147032
Biol Psychiatry. 2013 Jan 15;73(2):111-8
pubmed: 22784485
Psychophysiology. 2011 May;48(5):723-32
pubmed: 20874754
Front Hum Neurosci. 2012 May 31;6:149
pubmed: 22666197
AJNR Am J Neuroradiol. 2014 May;35(5):848-55
pubmed: 24029388
Neuroimage. 2007 Jan 1;34(1):235-42
pubmed: 17045492
Neuron. 2019 Apr 3;102(1):75-90
pubmed: 30946828
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Schizophr Res. 2000 Jan 21;41(2):303-12
pubmed: 10708339
Hum Brain Mapp. 2014 Apr;35(4):1436-45
pubmed: 23426796
Front Psychiatry. 2012 Oct 30;3:94
pubmed: 23115554
Am J Psychiatry. 2004 Jul;161(7):1264-9
pubmed: 15229060